Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel Versus Benchmark in Preventing Hypertrophic Scars and Improving Scar Appearance

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY

Evaluation of the safety and topical efficacy of a scar gel after 90 days of continuous use, comparing it to a benchmark for preventing hypertrophic scars and improving appearance, hydration and pigmentation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Participants of both sexes aged between 18 and 70 years;

• Participants with recent scars (\<30 days);

• Participants with phototypes III to VI according to the Fitzpatrick scale;

• Agree to follow the trial procedures and attend the center on the days and times determined for evaluations;

• Understand, agree to and sign the free and informed consent form.

• Types of scars: cesarean section, breast implant or blunt cut injury.

Locations
Other Locations
Brazil
MEDCIN
RECRUITING
Osasco
Medcin Instituto da Pele Ltda
NOT_YET_RECRUITING
Osasco
Contact Information
Primary
Flávia A. S. Addor
contato@medcinpesquisa.com.br
(55) 11 3683-5366
Time Frame
Start Date: 2025-04-03
Estimated Completion Date: 2025-12
Participants
Target number of participants: 80
Treatments
Active_comparator: Participants of both sexes, 18 - 70 y
Participants of both sexes, 18 - 70 y, who have recent scars.
Experimental: Exp.: Participants of both sexes, 18 - 70 y
Participants of both sexes, 18 - 70 y, with recent scars
Related Therapeutic Areas
Sponsors
Leads: Herbarium Laboratorio Botanico Ltda

This content was sourced from clinicaltrials.gov